Área Sanitaria da Coruña e Cee
Área sanitaria
Queen Mary University of London
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de Queen Mary University of London (39)
2024
-
Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry
Journal of Cardiac Failure
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
-
Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin
Frontiers in Cardiovascular Medicine, Vol. 11
-
Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction
Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004404
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure
European Heart Journal, Vol. 44, Núm. 48, pp. 5064-5073
2022
-
Association between use of enhanced recovery after surgery protocols and postoperative complications in colorectal surgery in Europe: The EuroPOWER international observational study
Journal of Clinical Anesthesia, Vol. 80
-
Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence
Cell Death and Disease, Vol. 13, Núm. 2
-
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases
The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 8, pp. e3313-e3320
2021
-
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
The Lancet Oncology, Vol. 22, Núm. 6, pp. 858-871
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Heart failure—emerging roles for the mitochondrial pyruvate carrier
Cell Death and Differentiation, Vol. 28, Núm. 4, pp. 1149-1158
-
NF-κB/IKK activation by small extracellular vesicles within the SASP
Aging Cell, Vol. 20, Núm. 7
-
Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial
European Journal of Cancer, Vol. 148, pp. 382-394
2020
-
Classical and Nonclassical Intercellular Communication in Senescence and Ageing
Trends in Cell Biology, Vol. 30, Núm. 8, pp. 628-639
-
European society of cardiology: Cardiovascular disease statistics 2019
European Heart Journal, Vol. 41, Núm. 1, pp. 12-85
-
Extracellular vesicles as potential tools for regenerative therapy
Molecular and Cellular Oncology, Vol. 7, Núm. 6
-
Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus
Circulation: Genomic and Precision Medicine, Vol. 13, Núm. 6, pp. E002769
-
Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy
Nature Metabolism, Vol. 2, Núm. 11, pp. 1223-1231
-
Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage
Cell Metabolism, Vol. 32, Núm. 1, pp. 71-86.e5